Colistin: all 30 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- Role of Inhaled Polymyxin as an Adjunct to Intravenous Therapy in Multidrug Resistant Ventilator-associated Pneumonia in Stroke PatientsNot yet recruitingNCT07865871Early Phase 1
- Optimising TREATment for Severe Gram-Negative Bacterial InfectionsRecruitingNCT07004049Phase 4
- Inhaled Colistin to Prevent Ventilator-Associated Pneumonia in Patients With Acute Brain InjuryRecruitingNCT06819462Not applicable
- IV Colistin for Pulmonary Exacerbations: Improving Safety and EfficacyCompletedNCT02918409Phase 4Results posted
- Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)CompletedNCT01597973Phase 3Results posted
- Comparative Study of Secondary Prophylaxis for SBPCompletedNCT06827756Phase 4
- Aerosolized Versus Intravenous Colistin-based Antimicrobial Regimens in Hospitalized COVID-19 Patients With Bacterial Coinfection: A Randomized Controlled TrialCompletedNCT05689229Phase 3
- Pharmacokinetics of Colistin in Critically Ill Patients With Extracorporeal Membrane OxygenationTerminatedNCT05542446Phase 4
- Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhotic PatientsStatus unknownNCT05279586Early Phase 1
- Colistin Intravenous Administration in Critically Ill Patients Suffering From Hospital Infections Caused by Multi-antibiotic-resistant Germs.Status unknownNCT04995133Phase 4
- Nebulized Colistin for Gram Negative VAP Prevention.Status unknownNCT04208945Not applicable
- The Effect of Colistin Inhalation on Ventilator Associated PneumoniaCompletedNCT03622450Phase 2/3
- Nebulized and Intravenous Colistin in Ventilator Associated-pneumoniaTerminatedNCT02906722Phase 3
- Effect of Aerosolised Colistin in Ventilator Associated PneumoniaCompletedNCT02683603Phase 4
- Therapy of Ventilator-associated Tracheobronchitis Caused by Gram Negative Bacteria With Nebulized ColistinStatus unknownNCT02619786Phase 3
- Eradication of Antibiotic-resistant Bacteria Through Antibiotics and Fecal BacteriotherapyStatus unknownNCT02472600Phase 2
- Safety and Efficacy Study of High Dose ColistinStatus unknownNCT02162966Phase 4
- Efficacy and Mortality of a Loading Dose of Colistin in Critical Ill PatientsStatus unknownNCT02117986Phase 4
- Colistin Pharmacokinetics in Continuous Renal Replacement TherapyStatus unknownNCT02081560Phase 4
- Efficacy of Ascorbic Acid for Prevention of Colistin-Associated NephrotoxicityStatus unknownNCT01501968Phase 3
- Comparison of 2 Treatment Regimens for Eradication of P Aeruginosa Infection in Children With Cystic FibrosisCompletedNCT01400750Phase 4
- Colistin Versus Colistin Plus Fosfomycin for Infections Caused by MDR Acinetobacter BaumanniiStatus unknownNCT01297894Phase 3
- Colistin Plus Rifampicin in MDR P. Aeruginosa and A. BaumaniiStatus unknownNCT01297855Phase 3
- Trial of Colistin Versus Meropenem in Ventilator-associated Pneumonia (VAP) (CR-GNB)CompletedNCT01292031Phase 3
- A Study Evaluating the Role of Oral Antibiotics in an Aim to Eradicate Carrier State of Carbapenem- Resistant Klebsiella Pneumonia (KPC).CompletedNCT01266499Not applicable
- Population Pharmacokinetic Study of Colistin in Patients Infected With Multiresistant Gram-negative BacteriaCompletedNCT01060891Phase 1
- Sino-nasal Inhalation of Colistin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa ColonizationCompletedNCT01035853Phase 2
- Nebulized Colistin for Hospital-Acquired PneumoniaStatus unknownNCT00920270Phase 3
- Intravenous Colistin Versus Intravenous Colistin Plus Nebulized Colistin in VAP Due MDR Acinetobacter BaumanniiStatus unknownNCT00645723Phase 3
- Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL Producing K.Pneumoniae or E.ColiStatus unknownNCT00300560Phase 3